{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:31:58Z","timestamp":1787959918939,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jjcc.2023.06.012","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T15:43:59Z","timestamp":1687794239000},"page":"105-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials"],"prefix":"10.1016","volume":"83","author":[{"given":"Kirtipal","family":"Bhatia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basera","family":"Sabharwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Persio D.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpanjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsimran K.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kruti Dhaval","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Niroula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edo Y.","family":"Birati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Argulian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arieh","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2023.06.012_bb0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jamacardio.2016.1161","article-title":"Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure","volume":"1","author":"Cleland","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0010","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0015","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0020","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure","volume":"58","author":"Okonko","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0025","doi-asserted-by":"crossref","unstructured":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines n.d. doi:https:\/\/doi.org\/10.1161\/CIR.0000000000001063.","DOI":"10.1161\/CIR.0000000000001063"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-2-1","article-title":"Simpson\u2019s paradox and calculation of number needed to treat from meta-analysis","volume":"2","author":"Cates","year":"2002","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0050","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0055","doi-asserted-by":"crossref","unstructured":"J Lau, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction, N Engl J Med n.d. https:\/\/doi.org\/10.1056\/NEJM199207233270406 (accessed March 28, 2023).","DOI":"10.1056\/NEJM199207233270406"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1536867X1301300106","article-title":"Trial sequential boundaries for cumulative meta-analyses","volume":"13","author":"Miladinovic","year":"2013","journal-title":"Stata J"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial sequential analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12874-020-01169-7","article-title":"Using Trial Sequential Analysis for estimating the sample sizes of further trials: example using smoking cessation intervention","volume":"20","author":"Claire","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002797","article-title":"Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: a trial sequential and cumulative meta-analysis","volume":"16","author":"Bajaj","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2307\/2336502","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0085","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","article-title":"Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency","volume":"50","author":"Toblli","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency","volume":"51","author":"Okonko","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0095","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0100","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ehf2.12250","article-title":"Single-dose intravenous iron in southeast Asian heart failure patients: a pilot randomized placebo-controlled study (PRACTICE-ASIA-HF): single-dose intravenous iron in Southeast Asian heart failure patients","volume":"5","author":"Yeo","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0110","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/FJC.0000000000001287","article-title":"IV sodium ferric gluconate complex in patients with iron deficiency hospitalized due to acute heart failure\u2014investigator initiated, randomized controlled trial","volume":"80","author":"Marcusohn","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0120","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00277-019-03777-w","article-title":"Iron deficiency in heart failure, an underdiagnosed and undertreated condition during hospitalization","volume":"98","author":"Mistry","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0125","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00392-021-01837-8","article-title":"Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials","volume":"110","author":"Graham","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0130","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/ejhf.2630","article-title":"Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial","volume":"24","author":"Metra","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0135","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/ejhf.1800","article-title":"Readmission and death in patients admitted with new-onset versus worsening of chronic heart failure: insights from a nationwide cohort","volume":"22","author":"Butt","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0140","doi-asserted-by":"crossref","first-page":"e008100","DOI":"10.1161\/CIRCHEARTFAILURE.120.008100","article-title":"Randomized placebo-controlled trial of ferric carboxymaltose in heart failure with iron deficiency: rationale and design","volume":"14","author":"Mentz","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0145","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/ejhf.2135","article-title":"Prevention of heart failure events with sodium\u2013glucose co-transporter 2 inhibitors across a spectrum of cardio-renal-metabolic risk","volume":"23","author":"Bhatia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2023.06.012_bb0150","doi-asserted-by":"crossref","unstructured":"Packer M. Potential interactions when prescribing SGLT2 inhibitors and intravenous iron incombination in heart failure. JACC Heart Fail n.d.;0. doi:https:\/\/doi.org\/10.1016\/j.jchf.2022.10.004.","DOI":"10.1016\/j.jchf.2022.10.004"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508723001570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508723001570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:08:58Z","timestamp":1760274538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508723001570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0914508723001570"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2023.06.012","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2023.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}